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The triggering of TLR7 and TLR9 in plasma-
cytoid DC (PDC) precursors and B cells by 
self–nucleic acids is key in the pathogenesis of 
systemic lupus erythematosus (SLE). This leads 
to the production of type I IFNs from PDCs 
that can be detected by the up-regulation of 
IFN-regulated genes in the blood of patients 
(IFN signature) and anti-DNA and anti-RNP 
antibodies from B cells that form immunocom-
plexes (ICs) with DNA or RNA from dying 
cells (for reviews see Marshak-Rothstein, 2006; 
Barrat and Coffman, 2008). IFN- and PDCs 
have been proposed to contribute to the patho-
genesis of other autoimmune diseases charac-
terized by IFN- signature as well. Indeed, type 
I IFN–producing PDCs accumulate in the pan-
creas, muscle, and salivary glands of people af-
fected by diabetes mellitus, dermatomyositis, 
and Sjögren’s syndrome, respectively, strongly 
suggesting that dysregulated PDC activation 
could be a more general feature of autoimmune 
disease (for reviews see Ueno et al., 2007; Barrat 
and Coffman, 2008; Guiducci et al., 2009).
PDCs and type I IFN appear to play a simi-
lar role in several cutaneous autoimmune dis-
eases, including lichen planus, dermatomyositis, 
lichen sclerosis, cutaneous graft versus host dis-
ease and the cutaneous forms of lupus (cutane-
ous lupus erythematosus [CLE]; for review see 
Wenzel and Tüting, 2008). The common path-
ological feature of these diseases is interface 
dermatitis, a specific inflammatory pattern 
characterized by (a) vacuolar changes (liquefac-
tion) of the basal layers of the epidermis, (b) the 
presence of apoptotic keratinocytes, (c) the 
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Recognition of endogenous DNA and RNA by cells expressing TLR7 and TLR9 is an impor-
tant contributor to the pathogenesis of systemic lupus erythematosus and has been sug-
gested to contribute to cutaneous lupus and to a group of related inflammatory skin 
diseases termed interface dermatitis. We have developed a mouse model of TLR7- and 
TLR9-dependent skin inflammation using tape stripping. In normal mice, this resulted in  
a rapid but transient inflammatory cell infiltration accompanied by induction of type I IFN 
production by plasmacytoid dendritic cells (PDCs) and release of extracellular traps and 
proinflammatory cytokines by neutrophils. These responses were strongly reduced in 
MyD88-deficient mice and in mice treated with a bifunctional inhibitor of TLR7 and TLR9. 
In contrast, in lupus-prone (NZBxNZW)F1 mice, tape stripping induced the development of 
chronic lesions characterized by a persistent type I IFN gene signature and many clinical 
and histological features of cutaneous lupus. Depletion of PDCs before injury prevented the 
development of skin lesions, whereas treatment with a bifunctional TLR7/9 inhibitor before 
tape stripping or after the initial lesion was established led to a significant reduction of the 
disease. These data suggest that inhibitors of TLR7 and TLR9 signaling have potential 
therapeutic application for the treatment of interface dermatitis.
© 2010 Guiducci et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). 
After six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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by the absence of an animal model reflecting the central 
features of such diseases. In this study, we report develop-
ment of a mouse model in which cutaneous injury by tape 
stripping leads to rapid infiltration and activation of PDCs 
and neutrophils. Although tape stripping causes a transient, 
self-limiting response in normal mice, the same treatment 
in a strain of lupus-prone mice produces a chronic lesion 
with many similarities to CLE. Our data thus suggest that 
when chronically activated, PDCs are a key player in inducing 
skin damage through sustained production of IFN-regulated 
genes as well as proinflammatory cytokines. Furthermore, 
we demonstrate that novel specific inhibitors of TLR7 
and TLR9 can prevent skin damage when used in thera-
peutic settings.
RESULTS
Activated PDCs and neutrophils infiltrate skin 
rapidly after tape stripping
As a method to induce mild cutaneous injury and 
inflammation, we used tape stripping, a method 
previously used to provoke disease in mouse 
models of psoriasis and atopic dermatitis (Inoue 
et al., 2005; Sano et al., 2005; Jin et al., 2009). 
Tape stripping has also been used as a noninvasive 
method for detecting and diagnosing lupus, as 
lupus patients overreact to this mild cutaneous 
injury compared with healthy individuals. How-
ever, the nature of the inflammatory response to 
tape stripping has not been well characterized at 
the cellular or molecular level. At 24 h after tape 
accumulation of cytotoxic CD8 T cells and neutrophils in 
the upper dermis, and (d) prominent IFN- signature in 
the skin. The close association between IFN-–producing 
PDCs and granzyme B–positive T cells together with accu-
mulation of nucleic acid–containing ICs at the junction of 
dermis and epidermis (for review see McCauliffe, 1996) 
suggests that the chronic presence of PDCs producing IFN- 
may play a central role in disease development (Blomberg 
et al., 2001; Farkas et al., 2001; for review see Wenzel and 
Tüting, 2008).
Despite this evidence implicating PDCs in autoimmune 
skin inflammation in humans (for review see Wenzel and 
Tüting, 2008), studies of the mode of activation of PDCs 
and their contribution to pathogenesis have been hampered 
Figure 1. Skin injury provokes leukocyte infiltration 
and activation, including production of IFN- by PDCs 
and secretion of NETs by neutrophils. (A and B) Cellular 
infiltrate in the skin of 129 mice was characterized before (A) 
and 24 h after inflammation via tape stripping (B) by flow 
cytometry. PDCs were identified as CD11C+PDCA1+120G8+, 
conventional DCs as CD11c+PDCA1120G8, neutrophils as 
Ly-6G+(1A8) F480, skin macrophages as F480+ Ly-6G low, 
and T cells as CD4+CD3+ and CD8+CD3+. Representative FACS 
plots of at least 10 mice processed from three independent 
experiments are shown. (C) 129 mice were tape stripped, and 
24 h later, PDC infiltrating cells were assessed for IFN- 
production by flow cytometry analysis. Neutrophils (Ly-6G+) 
and T cells (CD3+) were used as a negative control. Cultured 
BM-derived PDCs stimulated for 3 h with CpG-ISS were used 
as a positive control. A representative of three independent 
experiments (10 mice per experiments) with similar results is 
shown. (D and E) The ability of neutrophils to form NETs when 
isolated from BM (as source of inactivated neutrophils; D)  
or the skin of mice 24 h after tape stripping (E) was deter-
mined by immunostaining using Ly-6G to detect neutrophils 
and the SYTOX dye to stain DNA. (F and G) The presence of 
LL37-containing DNA (F) or RNA (G) NET fiber was detected 
by immunostaining using specific dyes. (D) Data from two 
independent experiments are shown. (E–G) Representative 
data from five fields from the skin of 10 mice from two inde-
pendent experiments are shown. Bars, 20 µm.
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The induction of these genes required MyD88, as shown by 
the lack of gene induction in MyD88-deficient mice (Fig. 2 A 
and Fig. S1 A). To define the regulation of these genes, we re-
peated the experiment using IFNAR/ mice that were 
lacking one chain of the type I IFN receptor. In these IFN-
/–unresponsive mice, IFIT1, ISG15, IRF7, and ISG20, all 
IFN-regulated genes, were not induced (Fig. 2 B and Fig. S1 B) 
in either compartment, and IP-10 was reduced in the skin 
(Fig. 2 B) but not in the infiltrating cells (Fig. S1 B). Another 
IFN-regulated gene, IFI202, was induced in IFNAR/ mice, 
which is consistent with previous studies showing an IFN-
independent signaling pathway for this gene in mice (for re-
views see Asefa et al., 2004; Choubey and Panchanathan, 
2008). In contrast, the lack of IFN-/ signaling did not re-
duce the induction of TNF, IL-1, or IL-1 (Fig. 2 B and 
Fig. S1 B). Instead, expression of these inflammatory genes was 
somewhat increased in the IFNAR/ in mRNA from total 
skin (Fig. 2 B) but not in infiltrating cells (Fig. S1 B), possibly 
reflecting the previously reported reciprocal regulation of the 
type I IFN and TNF pathways (for review see Banchereau 
et al., 2004). The clear requirement for MyD88 in the induc-
tion of all three proinflammatory genes demonstrates an im-
portant role for signaling through members of IL-1 receptor 
or Toll-like receptor (TLR) families.
To test whether the two nucleic acid–specific TLRs, 
TLR7 and TLR9, were involved in the induction of these in-
flammatory genes signatures, we treated tape-stripped mice 
with IRS 954, a bifunctional oligonucleotide antagonist 
which blocks activation by TLR7 or TLR9 agonists in vitro 
(Barrat et al., 2005) and in vivo (Barrat et al., 2007). Treatment 
with IRS 954 significantly reduced 
the expression of both IFN-–regulated 
genes and proinflammatory genes, in 
some cases reducing expression to the 
levels found in untreated mouse skin 
stripping, we observed a pronounced increase of inflamma-
tory cells in the skin (Fig. 1 B) compared with untreated skin 
(Fig. 1 A), including a cell population expressing the PDC 
markers CD11c+ and PDCA1+ (Fig.1 B) as well as 120G8+ 
and Ly-6C (not depicted). The PDCs are functionally active 
as they produce IFN-, measured by intracellular staining in 
cells isolated from the skin (Fig. 1 C). Flow cytometric analy-
sis also revealed a massive influx of neutrophils (Ly-6G+ cells) 
and a lesser increase in macrophages (F4/80+ cells) along with 
CD4+ and CD8+ T cells (Fig. 1 B).
Activated neutrophils produce neutrophil extracellular traps 
(NETs), which are essential to kill bacteria in vivo (Brinkmann 
et al., 2004; Fuchs et al., 2007; for review see Wartha and 
Henriques-Normark, 2008). Neutrophils infiltrating tape-
stripped skin are activated, producing abundant NETs with long 
chromatin fibers (Fig. 1 E), whereas no NET formation was ob-
served in unstimulated BM neutrophils that we used as controls 
(Fig. 1 D). In skin neutrophils, the long fibers of the NETs con-
tained both DNA and RNA and were associated with LL37/
CRAMP (Fig. 1, F and G), a cationic antimicrobial peptide 
secreted by activated neutrophils (Kessenbrock et al., 2009; for 
review see Wartha and Henriques-Normark, 2008).
Signaling through TLR7 and TLR9 leads to rapid induction 
of IFN-regulated and proinflammatory genes at the site  
of cutaneous injury
Accompanying the cellular infiltration, epidermal injury re-
sulted in strong induction of many prominent inflammatory 
genes in messenger RNA (mRNA) isolated from both skin 
biopsies and infiltrating leukocytes (Fig. 2 and Fig. S1). 
Figure 2. The MyD88 signaling pathway 
is necessary for the up-regulation of both 
type I IFN–regulated and proinflammatory 
genes. (A) MyD88/ (white bars) and age-
matched WT C57BL/6 mice (black bars) were 
either left untreated (naive) or tape stripped 
to provoke inflammation. 24 h later, skin  
biopsies were isolated, and the levels of pro-
inflammatory genes were evaluated by TaqMan. 
(B) IFNAR/ mice (white bars) and age-
matched WT 129 mice (black bars) were either 
left untreated (naive) or tape stripped to pro-
voke inflammation. 24 h later, skin biopsies 
were isolated, and the levels of proinflamma-
tory genes were evaluated by TaqMan. Naive 
(untreated) groups are shown for C57BL/6 
and 129 mice only. Cumulative data from at 
least two independent experiments (n = 15–20)  
are shown (mean ± SEM; *, P ≤ 0.05;  
**, P ≤ 0.01; ***, P ≤ 0.001).
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stripping in the individual receptor-deficient animals. We ob-
served partial reduction of the levels of gene expression in the 
skin after injury in either TLR7 (Fig. S4 A)- or TLR9 (Fig. S4 B)- 
deficient mice. However, none of the genes were exclu-
sively dependent on only one of these two receptors. As 
expected, the addition of the bifunctional TLR7/9 inhibi-
tor IRS 954 completed the inhibition in the TLR9-deficient 
animals (Fig. S4 B).
PDCs and neutrophils are responsible for different patterns 
of cytokine induction in response to tape stripping
To determine the relative contribution of each of these two 
prominent cell types in this model of skin inflammation, we 
specifically depleted each cell type before tape stripping. 
Depletion of PDCs with the 120G8 monoclonal antibody led 
to strong reduction of the type I IFN–regulated genes (IFI202, 
IFIT, ISG15, ISG20, and IP-10) in infiltrating cells (Fig. S5) 
and skin biopsies (Fig. 4), whereas these genes were relatively 
unaffected by depletion of neutrophils (Fig. 4 and Fig. S5). 
In contrast, neutrophil depletion resulted in a 70–90% reduc-
tion in TNF, IL-1, and IL-1 mRNA, whereas depletion of 
PDCs led to a more modest 20–50% reduction in the expres-
sion of these genes. Concurrent depletion of both cell types, 
as expected, resulted in large reductions in the expression of 
both groups of genes (unpublished data). Collectively, these 
results suggest that in this acute skin injury model, PDCs and 
neutrophils are major components of the TLR7-, TLR9-, and 
MyD88-dependent inflammation but promote two separate 
inflammatory responses, one regulated by the type I IFNs 
produced by PDCs and one that involves neutrophil-dependent 
proinflammatory cytokines.
Lupus-prone (NZBxNZW)F1 mice develop chronic skin 
lesions resembling human CLE after tape stripping
Patients with SLE or CLE are often much more sensitive to 
mild cutaneous irritation and injury, suggesting that injury 
initiates a process that is exacerbated and sustained by auto-
immune processes. Hybrid (NZBxNZW)F1 mice spontaneously 
develop high levels of circulating anti-DNA and RNA auto-
antibodies (for review see Furukawa and Yoshimasu, 2005), 
leading to IC formation and lupus nephritis resembling that 
observed in SLE patients. Although these mice rarely show 
spontaneous development of skin lesions, there is an accumu-
lation of ICs at the epidermis–dermis junction, similar to 
those observed in human CLE (for reviews see McCauliffe, 
1996; Furukawa and Yoshimasu, 2005). As ICs containing en-
dogenous RNA or DNA are potent ligands for TLR7 and 
TLR9, respectively (Barrat et al., 2005; Means et al., 2005), we 
postulated that (NZBxNZW)F1 mice could exhibit a pro-
longed or exacerbated response to tape stripping.
The initial response to tape stripping in (NZBxNZW)F1 
mice was very similar to that in normal mice, with involved 
skin showing a consistent increase in the number of PDCs 
and neutrophils (Fig. S6, A–C). The abundant cellular infil-
trate was accompanied by increased expression of IFN- 
regulated and proinflammatory genes. A single injection of 
(Fig. 3 B and Fig. S3). Thus, signaling through TLR7 and/or 
TLR9 is central to the principal gene expression changes in-
duced by tape stripping. In contrast, IRS 954 treatment had 
no measurable effect on the infiltration of cells, including 
PDCs and neutrophils (Fig. 3 B and Fig. S2), into the site of 
injury. This shows clearly that cell migration and cytokine se-
cretion, although they appear coordinately regulated, are in-
duced by different stimuli arising from tissue injury. We then 
further tested the role of each of these two receptors in the 
inflammatory response by measuring the response to tape 
Figure 3. Stimulation of TLR7 and TLR9 is required for the induc-
tion of skin inflammation but not for the cellular infiltration after 
skin injury. 129 mice were left untreated (naive; white bars), tape 
stripped (TAPE; black bars), or tape stripped immediately after treatment 
(s.c.) with 100 µg of the dual TLR7 and TLR9 inhibitor IRS 954. (A) 24 h 
later, skin-infiltrating cells were isolated, and PDCs and neutrophils were 
identified as in Fig. 1 A. Histograms show total cell number obtained from 
2 × 2–cm skin biopsies (n = 10 mice) from two independent experiments 
(mean ± SEM). (B) Gene expression levels were evaluated by TaqMan. 
Cumulative data from at least two independent experiments (n = 10–15 
mice) are shown (mean ± SEM; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001).
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ulceration, degree of 
intraepithelial, and 
dermal and pannic-
ulus inflammation, 
is shown in Table I. Overall disease score in lesions was sig-
nificantly higher in (NZBxNZW)F1 mice compared with 
normal mice.
PDCs and signaling through TLR7 and TLR9 are required  
for the initiation and maintenance of cutaneous lesions  
in (NZBxNZW)F1 mice
To demonstrate that PDCs and recognition of nucleic acids 
by TLR7 and TLR9 are central to the tape-stripping response 
in (NZBxNZW)F1 mice, animals were treated with IRS 954 
before skin injury and for the duration of the experiment, 
according to the schedule in Fig. S8. In contrast to untreated 
mice (Fig. 6, A, D, and F), IRS 954–treated mice healed com-
pletely or had small lesions (<15% of the stripped area; 
Fig. 6, B and D). Skin from IRS 954–treated mice showed 
a very mild hyperplasia of the epithelium with slight hyper-
keratosis and absence of ulceration. The inflammatory infiltrate 
and fibrotic reaction of the dermis appeared greatly reduced 
if compared with untreated animals, and no cellular infiltra-
tion was present in the epidermis (Fig. 6, G and H). Depletion 
of PDCs starting before tape stripping (Fig. S8) produced a 
very similar inhibition of the response to tape stripping. 
PDC-depleted mice had a normal appearance (Fig. 6, C and D) 
with normal to slight hyperplasic epithelium, negligible alter-
ations of the dermis, epidermis, and adnexa, and minimal 
presence of inflammatory infiltration of the dermis (Fig. 6, 
I and J). Histological disease score confirmed these results and 
showed a significant difference between untreated mice and 
mice treated with IRS 954 or depleted of PDCs (Table I). 
These results suggest that PDCs are key cells in the response 
to cutaneous injury through their ability to sense DNA and 
RNA through the two nucleic acid–specific TLRs expressed 
by PDCs.
To evaluate whether TLR7 and TLR9 signaling continues 
to be required for the prolonged response in (NZBxNZW)F1 
mice or is primarily involved in the initiation of the response, 
we delayed the first IRS 954 treatment until 4 d after the tape 
IRS 954 before tape stripping efficiently inhibited this gene 
induction, which is consistent with a role of TLR7 and TLR9 
in driving the acute response in this strain as well (Fig. S6 D). 
However, in contrast to the transient course of inflammation 
in normal mice, the inflammatory response in (NZBxNZW)F1 
mice was sustained for many days; mRNA for both IFN- 
regulated genes and proinflammatory cytokines remained sig-
nificantly elevated up to 3 wk after tape stripping (Fig. 5 A). 
This suggests that either these mice fail to properly resolve 
the inflammation or conditions exist to perpetuate the inflam-
matory signals once initiated by the injury of tape stripping. 
3 wk after tape stripping, skin lesions of (NZBxNZW)F1 mice 
extended over 50% of tape stripped area, whereas in normal 
mice, lesions were healed (Fig. 5, B and C). At very early time 
points, 1 and 4 d after tape stripping, (NZBxNZW)F1 mice 
had severe multifocal thinning of the epidermis with epider-
mal necrosis and diffuse dermoepidermal leukocytic infiltrates 
composed largely of neutrophils and macrophages (unpub-
lished data). By about 3 wk after the initial tape stripping, 
(NZBxNZW)F1 mice showed prominent epidermal hyper-
plasia with hyperkeratosis, keratin-filled craters or cysts, der-
mal fibrosclerosis, and degenerative changes of the s.c. fat 
tissue (Fig. 5, G–I and Fig. S7). In man, epidermal changes and 
vacuolar degeneration of the dermoepidermal junction are 
characteristic of all the forms of CLE, whereas other features 
of this model such as the presence of keratin-filled cysts and 
the degeneration of s.c. fat are more prominent in discoid 
CLE and verrucous discoid CLE (for review see Baltaci and 
Fritsch, 2009). Cutaneous lesions in (NZBxNZW)F1 mice 
showed persistent leukocytes infiltration, composed mainly of 
neutrophils, macrophages, and T cells, involving the epider-
mis, dermis, and adnexa as well as the s.c. fat (Fig. 5, G–I and 
Fig. S7). In the nonautoimmune mouse strains, 129 and 
C57BL/6, although a transient inflammation was observed 
involving the dermis (early time points 1 and 4 d; not de-
picted), it resolved spontaneously without producing sclerotic 
lesions, and at the same time points, infiltrating leukocytes 
were scarce and similar in number to untreated control skin 
(Fig. 5, E and F). A systematic review of the histopathological 
changes, based on the semiquantitative evaluation of multiple 
disease parameters including epidermis thickness, degree of 
Figure 4. The activation of both PDCs 
and neutrophils is critical for the burst of 
inflammatory genes after tape-stripping 
injury. 129 mice were either left untreated or 
tape stripped. PDCs and/or neutrophils were 
depleted before tape stripping using specific 
antibodies (250 µg given i.p. at day 2, day 0, 
and 8 h before tape stripping). Anti-120G8 
antibody was used for depletion of PDCs and 
anti-GR1–Ly-6G antibody for depletion of 
neutrophils (Neut). Over 95% cellular deple-
tion was achieved in both blood stream  
and skin infiltrate. 24 h after tape stripping, 
gene expression levels were measured in skin 
biopsies. Naive groups are shown for un-
treated mice only. Cumulative data from three 
independent experiments (n = 14 mice) are 
shown (mean ± SEM; *, P ≤ 0.05; **, P ≤ 0.01; 
***, P ≤ 0.001).
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and fibrosclerosis and negligible in-
volvement of the adipose tissue (Fig. 7, 
F and G; and Table I). In summary, 
these findings demonstrate that the 
chronic activation of TLR7 and/or 
TLR9 in PDCs is required both to 
initiate and maintain the inflamma-
tion in the skin of (NZBxNZW)F1 
mice. It also suggests that blocking this 
process with a specific TLR7/9 inhib-
itor such as IRS 954 is effective in a 
therapeutic setting, acting to resolve 
ongoing skin inflammation.
DISCUSSION
CLE belongs to a group of diseases 
named interface dermatitis (for review 
see Wenzel and Tüting, 2008) that 
shares a pattern of epidermal changes 
characterized by large areas of lique-
faction at the derma–epidermal junc-
tion. The specific causes of these 
diseases are unknown, although the infiltration of IFN-–
producing PDCs in the area of vacuolization has been sug-
gested to play a role in either initiating the disease and/or 
maintaining its chronicity (Farkas et al., 2001; for reviews see 
Wenzel and Tüting, 2007, 2008). The pathogenic effect of 
IFN- in the skin could be explained in part by the induc-
tion of IFN-regulated cytokines such as IP-10, which induce 
the infiltration of pathogenic CXCR3+ T cells (for review see 
stripping, at a time when the lesions were fully developed. 
Strikingly, the cutaneous lesions of mice treated with IRS 954 
beginning at day 4 were almost completely healed by day 15–23 
with only 10% of the surface still covered by open lesions 
(Fig. 7, B and C). In contrast, untreated animals had substan-
tial unhealed lesions (Fig. 7, A and C–E) at these time points. 
Skin specimens from IRS 954–treated mice presented moderate 
alterations with very modest dermal inflammatory infiltration 
Figure 5. Lupus-prone (NZBxNZW)F1 
mice develop a severe and chronic skin 
disease resembling human CLE after tape 
stripping. (A) Lupus-prone mice (NZBxNZW)F1 
and age-matched 129 and C57BL/6 mice were 
tape stripped, skin biopsies were collected 24 h, 
4 d, and 20 d later, and gene expression was 
evaluated. The levels of expression at 24 h 
were set as 100 and compared with levels 
obtained at 4 d and 20 d after tape stripping. 
Cumulative data from three independent 
experiments are shown (n = 10; mean ± SEM; 
*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (B) 
Macroscopic lesions in (NZBxNZW)F1 at 15–23 d 
after tape stripping as compared with normal 
129 mice. (C) Quantification of area with open 
lesions 15–23 d after tape stripping in 
(NZBxNZW)F1, 129, and C57BL/6 mice. Cumu-
lative data from at least two independent 
experiments (n = 15; mean ± SEM) are shown. 
(D–I) Representative sections of skin from 
untouched (NZBxNZW)F1 mice (D) or from the 
skin of 129 (E), C57BL/6 (F), or (NZBxNZW)F1 
mice (G–I) 15–23 d after tape stripping.  
(D–I) Representative sections from >20 mice 
are shown. Bars, 200 µm.
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Wenzel and Tüting, 2008). In addition, IFN- has been shown 
to boost cytotoxic activity of T cells and to activate neutro-
phils to produce reactive oxygen intermediates, which medi-
ate end-organ damage (Martinelli et al., 2004). Neutrophils 
that accumulate abundantly in the early phase of CLE lesions 
(for review see Lipsker and Saurat, 2008) also express both 
TLR7 and TLR9. Ligation of Fc- receptors by ICs activates 
these cells to produce proinflammatory cytokines, reactive 
oxygen intermediates, and proteases (Coxon et al., 2001; 
Hayashi et al., 2003; Tsuboi et al., 2008), thus playing an im-
portant role in the liquefaction process typical of CLE 
(Hayashi et al., 2003; for reviews see  Lipsker and Saurat, 2008; 
Baltaci and Fritsch, 2009). Both type I IFNs and proinflam-
matory cytokines such as TNF, IL-1, and IL-1 are abun-
dantly expressed in CLE and can promote the migration of 
inflammatory cells to the skin (Popovic et al., 2005; for re-
view see  Werth, 2007).
Studies of the pathogenic mechanisms of CLE and devel-
opment of new therapies for CLE have been hampered by the 
absence of animal models of interface dermatitis that replicate 
key features and pathways of the human disease (for review 
see Wenzel and Tüting, 2008). In this study, we report that skin 
injury caused by tape striping in normal mice is followed by 
an acute inflammatory response accompanied by conspicuous 
infiltration of innate immune cells, including PDCs and neu-
trophils, paralleled with induction of type I IFN–regulated 
genes and proinflammatory cytokines. This increased expres-
sion of cytokine genes is completely abrogated in MyD88-
deficient mice and in mice treated with a specific inhibitor of 
TLR7 and TLR9, indicating a central role for stimulation by 
RNA and/or DNA. Among the leukocytes that infiltrate the 
lesional skin, both PDCs and neutrophils express TLR7 and 
TLR9 receptors (Kadowaki et al., 2001; Edwards et al., 2003; 
Hayashi et al., 2003). The magnitude and composition of the 
cellular infiltrate are not significantly altered by TLR7 and 
TLR9 inhibition, suggesting that these pathways are not re-
quired for extravasation and homing. Using specific depleting 
antibodies, we demonstrate that PDCs, not neutrophils, are 
the source of type I IFN response, whereas proinflammatory 
cytokines IL-1, IL-1, and TNF are profoundly inhibited by 
neutrophil depletion. The reduction in cytokine gene expression 
in skin depleted of PDCs or neutrophils is similar in RNA 
samples extracted from infiltrating leukocytes or from whole 
skin biopsies, suggesting that keratinocytes or endothelial cells 
are not major contributors to this gene expression pattern. 
The finding that both IRS 954 and neutrophil depletion inhibit 
proinflammatory cytokines to a similar extent suggests that 
neutrophils do respond directly through one or both of these 
receptors. Alternatively, the inhibition of TLR7 and TLR9 may 
prevent induction of a factor made by another cell type (not 
PDCs) that activates neutrophils. The absence of TLR9 exac-
erbated disease in MRL/lpr lupus-prone mice, suggesting that 
TLR9 itself has a protective role in developing autoimmune 
inflammatory disorders (Christensen et al., 2006; Nickerson 
et al., 2010). However, we did not observe any exacerbation 
of skin inflammation in the TLR9-deficient animals.
The most likely ligands for TLR7 and TLR9 in injured 
skin are endogenous nucleic acids released from keratinocytes 
and other cell types dying as a consequence of mechanical 
injury or neutrophil cytotoxicity. Another potential source 
would be DNA specifically extruded from neutrophils in the 
form of NETs. This is not likely the major source of the initial 
TLR stimulation, as neutrophil depletion before injury does 
not significantly reduce the activation of PDCs (Fig. 4 and 
Fig. S5); however, this may be a relevant source in the chronic 
activation observed in autoimmune mice. Tissue injury in a 
largely sterile environment has been shown to stimulate a similar 
nucleic acid–dependent inflammatory response. Indeed, DNA 
release from necrotic hepatocytes stimulates cytokine produc-
tion by neutrophils in a TLR9-dependent manner, and this 
has been suggested to be a primary mechanism of liver dam-
age after some forms of hepatic injury (Imaeda et al., 2009; 
Bamboat et al., 2010).
In 129 or C57BL/6 mice, the burst of mRNA encoding 
inflammatory cytokines is transient, and gene expression 
levels return to pretreatment levels within 10 d of tape strip-
ping. This is paralleled by reduction in cellular infiltration and 
progressive wound healing (unpublished data). Thus, this 
model represents an acute activation of pathways that are ac-
tivated chronically in lupus, CLE, and related diseases. In con-
trast, tape stripping of lupus-prone (NZBxNZW)F1 mice 
produces a lesion quite similar to that in nonautoimmune 
Table I. Pathologic evaluation of skin lesions after tape stripping
Treatment groups Epidermis 
thickness
Ulceration Intraepithelial 
inflammation
Dermal 
inflammation
Panniculum 
inflammation
Total disease score
(NZBxNZW)F1 mice 2.9 ± 1.7 1.6 ± 0.2 1.0 ± 0.16 2.3 ± 0.14 1.7 ± 0.12 8.4 ± 0.6
C57BL/6 mice 0.4 ± 0.3a 0.4 ± 0.4b 0.4 ± 0.4b 0.8 ± 0.2a 1.4 ± 0.3b 3.4 ± 0.8a
129 mice 1.0 ± 0.2a 0.0 ± 0.0a 0.0 ± 0.0a 1.6 ± 0.2a 1.2 ± 0.2a 3.1 ± 0.4a
(NZBxNZW)F1 + IRS 954 (pre-injury) 0.7 ± 0.2a 0.0 ± 0.0a 0.2 ± 0.2b 1.3±0.2a 0.8 ± 0.1a 3.2 ± 0.5a
(NZBxNZW)F1 + IRS 954 (therapeutic) 1.0 ± 0.2a 0.2 ± 0.1a 0.2 ± 0.2a 1.2 ± 0.1a 1.0 ± 0.0a 3.5 ± 0.4a
(NZBxNZW)F1 depleted of PDCs 1.4 ± 0.3b 0.1 ± 0.1a 0.1 ± 0.1b 1.4 ± 0.2a 1.0 ± 0.2a 4.0 ± 0.5a
15–23 d after tape stripping, each of the histological features was scored singularly and graded 1 to 3 as indicated in Materials and methods; the overall disease score was 
calculated by combining the scores for each parameter. Data are from three to four different independent experiments (n = 12–30; mean ± SEM).
aP < 0.001 as compared with the (NZBxNZW)F1 group.
bP < 0.05 as compared with the (NZBxNZW)F1 group.
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strains, but instead of healing spontaneously, it evolves into le-
sions that resemble the human CLE situation both clinically 
and histologically. The inflammation is mediated by TLR7 
and TLR9 as the treatment of (NZBxNZW)F1 mice with the 
specific TLR7/9 inhibitor IRS 954 is able to prevent disease 
onset as shown by gross appearance of the skin, histological 
examination, and the normalization of the gene signatures. 
TLR7 and TLR9 activation is required not only for the in-
duction of the inflammatory response but also for continua-
tion of the chronic response seen in lupus-prone mice. This is 
shown clearly by the fact that IRS 954 treatment initiated 
after the development of the initial cellular infiltrate and cu-
taneous lesions leads to accelerated healing. This finding iden-
tifies TLR7 and TLR9 as important potential targets for 
therapy in CLE and related cutaneous autoimmune diseases.
Although the initial source of TLR ligands may be similar 
in normal and autoimmune mice, an important difference 
may be the continued presence of ligands for TLR7 and 
TLR9 in (NZBxNZW)F1 mice, specifically the ICs that ac-
cumulate at the dermis–epidermis junction (for reviews see 
McCauliffe, 1996; Furukawa and Yoshimasu, 2005) and the 
presence of circulating anti-DNA and RNA autoantibodies 
in these mice (for review see Furukawa and Yoshimasu, 2005). 
A similar phenomenon might take place in human CLE, 
where anti-DNA and RNA ICs in circulation and deposited 
in skin tissue have been extensively described (for reviews see 
McCauliffe, 1996; Wenzel and Tüting, 2008). Another source 
of DNA and RNA for this continued stimulation might be 
the neutrophils themselves. Skin neutrophils are highly acti-
vated after tape stripping and produce abundant NET fibers 
containing DNA and RNA molecules. NET-producing neu-
trophils were found in normal mice only at early time points, 
before the inflammatory response is resolved. However, 
in (NZBxNZW)F1 mice, significant infiltration of NET- 
producing neutrophils is detectable at later time points in 
well-established lesions (unpublished data), suggesting that 
they may constitute a source of endogenous nucleic acid lead-
ing to chronic TLR signaling. Interestingly, we found that the 
antimicrobial peptide LL37/CRAMP was associated with the 
fibers of the NETs from skin neutrophils. LL37/CRAMP is a 
cationic antimicrobial peptide highly inducible in keratino-
cytes and has been shown to convert endogenous DNA and 
RNA into a potent TLR9 or TLR7 agonists by promoting 
aggregation and enhanced uptake by PDCs in vitro (Lande 
et al., 2007; Ganguly et al., 2009). In addition to self-DNA/
RNA, it is possible that microbial nucleic acids can participate 
in this process either directly by activating the TLRs or 
Figure 6. PDCs and TLR7 and TLR9 signaling are required for  
cutaneous disease formation in lupus-prone mice. (A–C) Macroscopi-
cal skin lesions 15–23 d after tape stripping in (NZBxNZW)F1 mice (A), 
(NZBxNZW)F1 treated with weekly injection of IRS 954 (B), and 
(NZBxNZW)F1 mice in which PDCs were depleted during the course of the 
experiment (C; see Fig. S8). (D) Quantification of area with open lesions 
15–23 d after tape stripping in mice as in A–C. Cumulative data from at 
least two independent experiments (n = 12; mean ± SEM; *, P ≤ 0.05;  
**, P ≤ 0.01) are shown. (E–J) Representative sections of skin from  
untouched (NZBxNZW)F1 mice (naive; E) or from skin isolated 15–23 d 
after tape stripping from (NZBxNZW)F1 mice left untreated (F) or treated 
with IRS 954 (G and H) or depleted of PDCs (I and J). Representative sec-
tions from 15 mice are shown. Bars, 200 µm.
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with interface dermatitis. We also demonstrate that using novel 
oligonucleotide-based inhibitors of TLR7 and TLR9 could 
prove to be valuable therapeutics for skin autoimmune diseases.
MATERIALS AND METHODS
Reagents. Phosphorothioate oligodeoxynucleotides were prepared as 
previously described (Duramad et al., 2003). The prototype for inhibitor of 
TLR7 and TLR9 used was IRS 954, 5-TGCTCCTGGAGGGGTTGT-3 
(Barrat et al., 2005). Control oligonucleotide was 5-TCCTGCAGGT-
TAAGT-3. Mouse IFN- ELISA sets were purchased from PBL Bio-
medical Laboratories.
Animals and in vivo treatments. C57BL/6 and 129 mice were purchased 
from Charles River. We purchased (NZBxNZW)F1 female mice from The 
Jackson Laboratory and used them at 18–22 wk of age. MyD88/KO and 
TLR9/KO mouse colonies were maintained at Simonsen Laboratories and 
were used with age-matched C57BL/6 WT controls at 8–12 wk of age. Ani-
mal experiments were conducted at MuriGenics. All animal experiments 
were approved by the institutional animal care and use committee of Muri-
Genics, in conformity with the Guide for the Care and Use of Laboratory 
Animals (National Research Council).We performed tape stripping after 
shaving the dorsal area (3 × 3 cm) using 10 strokes with duct tape. IRS 954 
was administered just before tape stripping s.c. at a distant site. Alternatively, 
in (NZBxNZW)F1 mice, IRS 954 was administered long term, as depicted 
in Fig. S8. In certain experiments, PDCs and neutrophils were depleted with 
250 µg IRS 954 given i.p. at day 2, day 0, and 8 h before tape stripping. We 
used anti-120G8 (Imgenex) for depletion of PDCs (Asselin-Paturel et al., 
2003) and anti–GR1-Ly-6G (clone 1A8; BioLegend) for depletion of neu-
trophils (Daley et al., 2008). Over 95% cellular depletion was achieved in 
both blood stream and skin infiltrate. In experiments in which PDCs were 
depleted, long-term 120G8-depleting antibody 
was administered as depicted in Fig. S8. Experi-
ments in (NZBxNZW)F1 mice were termi-
nated between 15 and 23 d after initial tape 
stripping, depending on the progression of the 
lesions in the untreated groups in each experi-
ment. The percentage of area with open lesions 
in (NZBxNZW)F1 and normal mice was evalu-
ated with NIS-elements software (Nikon).
Histological analysis of skin inflammation 
and tissue pathology. The biopsy specimens 
were fixed in formalin and embedded in paraf-
fin. Sections were stained with hematoxylin and 
indirectly by promoting the release of NETs by neutrophils. 
This is particularly relevant to the chronic model in which 
the skin is exposed for a long period of time.
The development of cutaneous lesions after injury in 
lupus-prone mice is similar to the Koebner phenomenon ob-
served in patients with CLE and other autoimmune disease of 
the skin after skin trauma (for review see Ueki, 2005). The 
development of the lesions in (NZBxNZW)F1 is character-
ized by a persistent IFN signature and a high level of proin-
flammatory mediators such as IL-1, IL-1, and TNF similarly 
to the situation in human CLE (Werth et al., 2002; Clancy 
et al., 2004; Popovic et al., 2005; for review see Werth, 2007). 
The absence of spontaneous macroscopic lesions in lupus-
prone mice is expected as most mouse model skin diseases 
require mild wounding (Spergel et al., 1999; Sano et al., 2005; 
Matsunaga et al., 2007).
In conclusion, we provide evidence that an abnormal re-
sponse to endogenous ligands leading to chronic activation of 
both TLR7 and TLR9 may constitute a fundamental trigger 
of autoimmunity in the skin. The difference in outcome in 
lupus-prone versus normal mice after mild injury in the skin 
thus reflects the nature of the response, acute versus chronic, 
by PDCs and neutrophils to nucleic acids in the skin. Our 
data suggest that an abnormal/chronic response to TLR7 and 
TLR9 ligands can establish a self-perpetuating inflammatory 
loop driving diseases such as cutaneous lupus or other diseases 
Figure 7. Therapeutic treatment of  
lupus-prone mice with chronic skin in-
flammation using IRS 954 significantly 
ameliorates CLE-like phenotype.  
(A and B) Gross appearance of skin lesions 
isolated 15–23 d after tape stripping from 
(NZBxNZW)F1 mice left untreated or 
(NZBxNZW)F1 mice treated from day 4–20 with 
IRS 954 in a therapeutic setting (scheme of 
treatment in Fig. S8). (C) Quantification of area 
with open lesions 15–23 d after tape stripping 
in mice as in A and B. Cumulative data from 
two independent experiments (n = 12; mean ± 
SEM; **, P ≤ 0.01) are shown. (D–G) Represen-
tative sections of skin from (NZBxNZW)F1 mice 
either left untreated (D and E) or treated from 
day 4 with IRS 954 (F and G). Data show rep-
resentative sections of 12 mice. Bars, 200 µm.
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according to the manufacturer’s instructions. RNA and cDNA were generated 
with SuperScript First-Strand Synthesis System (Invitrogen). RCT threshold 
cycle (CT) values for each gene were normalized to the housekeeping gene 
ubiquitin using the formula gene expression = 1.8(Avg CT Ubi  CT 
Gene) × 100,000, where Ubi is the mean CT of triplicate housekeeping 
gene runs, Gene is the mean CT of duplicate runs of the gene of interest, and 
100,000 is arbitrarily chosen as a factor to bring all values above 1. Primers 
sequences used were as follows: IFI202R, 5-CTAGGATGCCACTGCT-
GTTG-3; IFI202F, 5-CAAGCCTCTCCTGGACCTAA-3; IRF7R, 
5-TCCAAGCTCCCGGCTAAGT-3; IRF7F, 5-ACAGGGCGTTT-
TATCTTGCG-3; ISG15R, 5-CCCCTTTCGTTCCTCACCAG-3; 
ISG15F, 5-ACGGTCTTACCCTTTCCAGTC-3; ISG20R, 5-CCAC-
CAGCTTGCCTTTCAGAA-3; ISG20F, 5-GTCACGCCTCAGCA-
CATGGT-3; NMIR, 5-AATGCCTTCTAATCCGGTCA-3; NMIF, 
5-AGTGGAAAGCGTGGATTATGA-3; IFIT1R, 5-TCTGGATTTA-
ACCGGACAGC-3; IFIT1F, 5-AGGCTGGAGTGTGCTGAGAT-3; 
IL-1AR, 5-CCGACAGCACGAGGCTTT-3; IL-1AF, 5-TGGTGT-
GTGACGTTCCCATT-3; TNF-AR, 5-GGTCTGGGCCATAGAACT-
GATG-3; TNF-AF, 5-GCCACCACGCTCTTCTGTCT-3; IL-1BR, 
5-AAACCGTTTTTCCATCTTCTTCTTT-3; IL-1BF, 5-GACGGC-
ACACCCACCCT-3; IP-10F, 5-GACGGTCCGCTGCAACTG-3; and 
IP-10R, 5-GCTTCCCTATGGCCCTCATT-3.
Statistical analysis. Data were analyzed using a two-tailed Student’s t test. 
All analyses were performed using Prism software (GraphPad Software, Inc.). 
Differences were considered significant at a P-value of <0.05.
Online supplemental material. Fig. S1 shows that the up-regulation 
of type I IFN–regulated genes in skin-infiltrating cells in normal mice is 
IFNAR dependent. Fig. S2 shows that TLR7 and TLR9 inhibition does not 
affect the ability of leukocytes to infiltrate the injured skin. Fig. S3 shows that 
stimulation of TLR7 and TLR9 is necessary for the up-regulation of type I 
IFN–regulated genes and inflammatory genes as measured in RNA samples 
from skin biopsies. Fig. S4 shows that the up-regulation of type I IFN–regulated 
genes and inflammatory genes is dependent on both TLR7 and TLR9 re-
ceptors. Fig. S5 shows that the activation of both PDCs and neutrophils is 
critical for the burst of inflammatory genes after tape-stripping injury. Fig. S6 
shows that in lupus-prone mice, (NZBxNZW)F1 , tape stripping is followed 
by up-regulation of type I IFN–regulated genes and inflammatory genes in 
a TLR7- and TLR9-dependent way. Fig. S7 shows histopathological details 
in lesions of (NZBxNZW)F1 at high magnification. Fig. S8 depicts the treat-
ment protocols in (NZBxNZW)F1 with the TLR7 and TLR9 inhibitor IRS 
954 and in the PDC-depleting experiments. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20101048/DC1.
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